97 related articles for article (PubMed ID: 8216350)
1. Prevention of insulin-dependent diabetes mellitus by 2'-deoxycoformycin in the BB Wistar rat.
Thliveris JA; Begleiter A; Kobrinsky NL; Verburg L; Dean HJ; Johnston JB
Biochem Pharmacol; 1993 Sep; 46(6):1071-5. PubMed ID: 8216350
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for insulin-dependent diabetes mellitus in the "BB" rat.
Thliveris JA; Begleiter A; Manchur D; Johnston JB
Life Sci; 1997; 61(3):283-91. PubMed ID: 9217288
[TBL] [Abstract][Full Text] [Related]
3. Functional status of the immune system after chronic administration of 2'-deoxycoformycin in the BB rat.
Thliveris JA; HayGlass KT; Manchur D; Rector E; Begleiter A; Johnston JB
Histol Histopathol; 2000 Jan; 15(1):21-7. PubMed ID: 10668191
[TBL] [Abstract][Full Text] [Related]
4. Rat brain adenosine deaminase after 2'-deoxycoformycin administration: biochemical properties and evidence for reduced enzyme levels detected by 2'-[3H]deoxycoformycin ligand binding.
Padua RA; Geiger JD; Delaney SM; Nagy JI
J Neurochem; 1992 Feb; 58(2):421-9. PubMed ID: 1729390
[TBL] [Abstract][Full Text] [Related]
5. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
Barton RW
Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160
[TBL] [Abstract][Full Text] [Related]
6. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
[TBL] [Abstract][Full Text] [Related]
7. Morphologic changes and immunohistochemical localization of adenosine deaminase in tissues of rats given injections of 2'-deoxycoformycin.
Checkik BE; Perets A; SenGupta S; Fernandes B
J Natl Cancer Inst; 1983 Nov; 71(5):999-1010. PubMed ID: 6358608
[TBL] [Abstract][Full Text] [Related]
8. 2'-Deoxycoformycin inhibition of adenosine deaminase in rat brain: in vivo and in vitro analysis of specificity, potency, and enzyme recovery.
Padua R; Geiger JD; Dambock S; Nagy JI
J Neurochem; 1990 Apr; 54(4):1169-78. PubMed ID: 2179470
[TBL] [Abstract][Full Text] [Related]
9. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin.
Johnston JB; Lee K; Verburg L; Blondal J; Mowat MR; Israels LG; Begleiter A
Leuk Res; 1992 Aug; 16(8):781-8. PubMed ID: 1528066
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and immunosuppressive activity of binary combinations of 2'-deoxycoformycin and 2'-deoxyadenosine.
Paine RM; Weston BJ; Clink HM; Kohn J; Neville AM; McGhee KG; Harrap KR
Cancer Treat Rep; 1981; 65(3-4):259-66. PubMed ID: 6972254
[TBL] [Abstract][Full Text] [Related]
12. Specific immunosuppressive effects of constant infusion of 2'-deoxycoformycin.
Trotta PP; Tedde A; Ikehara S; Pahwa R; Good RA; Balis ME
Cancer Res; 1981 Jun; 41(6):2189-96. PubMed ID: 6972248
[TBL] [Abstract][Full Text] [Related]
13. An adenosine deaminase inhibitor prevents puromycin aminonucleoside nephrotoxicity.
Nosaka K; Takahashi T; Nishi T; Imaki H; Suzuki T; Suzuki K; Kurokawa K; Endou H
Free Radic Biol Med; 1997; 22(4):597-605. PubMed ID: 9013123
[TBL] [Abstract][Full Text] [Related]
14. Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2'-deoxycoformycin and 2'-deoxyadenosine: association with dATP-dependent activation of caspase-3.
Niitsu N; Yamaguchi Y; Umeda M; Honma Y
Blood; 1998 Nov; 92(9):3368-75. PubMed ID: 9787175
[TBL] [Abstract][Full Text] [Related]
15. Deoxyadenosine triphosphate acting as an energy-transferring molecule in adenosine deaminase inhibited human erythrocytes.
Nakashima K; Nakashima H; Shimoyama M
Biochim Biophys Acta; 1991 Sep; 1094(3):257-62. PubMed ID: 1911876
[TBL] [Abstract][Full Text] [Related]
16. Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.
Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R
Pharmacol Res; 2007 Aug; 56(2):124-31. PubMed ID: 17574432
[TBL] [Abstract][Full Text] [Related]
17. CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells.
Iwaki-Egawa S; Watanabe Y; Fujimoto Y
Cell Immunol; 1997 Jun; 178(2):180-6. PubMed ID: 9225009
[TBL] [Abstract][Full Text] [Related]
18. [Influence of iron deficiency anemia on development of thymus and spleen and adenosine deaminase activity in rats].
Luo C; Chen J; Liao Q; Li Q; Yang X; Li Y
Hua Xi Yi Ke Da Xue Xue Bao; 1990 Mar; 21(1):63-6. PubMed ID: 2365344
[TBL] [Abstract][Full Text] [Related]
19. Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms.
Kutryb-Zajac B; Koszalka P; Mierzejewska P; Bulinska A; Zabielska MA; Brodzik K; Skrzypkowska A; Zelazek L; Pelikant-Malecka I; Slominska EM; Smolenski RT
J Cell Mol Med; 2018 Dec; 22(12):5939-5954. PubMed ID: 30291675
[TBL] [Abstract][Full Text] [Related]
20. Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors.
Golembiowska K; White TD; Sawynok J
Brain Res; 1995 Nov; 699(2):315-20. PubMed ID: 8616636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
